• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

World J Emerg Med . Artificial intelligence computed tomography helps evaluate the severity of COVID-19 patients: A retrospective study

tetano

Editor, Senior Moderator
World J Emerg Med


. 2022;13(2):91-97.
doi: 10.5847/wjem.j.1920-8642.2022.026.
Artificial intelligence computed tomography helps evaluate the severity of COVID-19 patients: A retrospective study


Yi Han[SUP] 1 [/SUP], Su-Cheng Mu[SUP] 1 [/SUP], Hai-Dong Zhang[SUP] 2 [/SUP], Wei Wei[SUP] 1 [/SUP], Xing-Yue Wu[SUP] 1 [/SUP], Chao-Yuan Jin[SUP] 1 [/SUP], Guo-Rong Gu[SUP] 1 [/SUP], Bao-Jun Xie[SUP] 2 [/SUP], Chao-Yang Tong[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Computed tomography (CT) is a noninvasive imaging approach to assist the early diagnosis of pneumonia. However, coronavirus disease 2019 (COVID-19) shares similar imaging features with other types of pneumonia, which makes differential diagnosis problematic. Artificial intelligence (AI) has been proven successful in the medical imaging field, which has helped disease identification. However, whether AI can be used to identify the severity of COVID-19 is still underdetermined.
Methods: Data were extracted from 140 patients with confirmed COVID-19. The severity of COVID-19 patients (severe vs. non-severe) was defined at admission, according to American Thoracic Society (ATS) guidelines for community-acquired pneumonia (CAP). The AI-CT rating system constructed by Hangzhou YITU Healthcare Technology Co., Ltd. was used as the analysis tool to analyze chest CT images.
Results: A total of 117 diagnosed cases were enrolled, with 40 severe cases and 77 non-severe cases. Severe patients had more dyspnea symptoms on admission (12 vs. 3), higher acute physiology and chronic health evaluation (APACHE) II (9 vs. 4) and sequential organ failure assessment (SOFA) (3 vs. 1) scores, as well as higher CT semiquantitative rating scores (4 vs. 1) and AI-CT rating scores than non-severe patients (P<0.001). The AI-CT score was more predictive of the severity of COVID-19 (AUC=0.929), and ground-glass opacity (GGO) was more predictive of further intubation and mechanical ventilation (AUC=0.836). Furthermore, the CT semiquantitative score was linearly associated with the AI-CT rating system (Adj R [SUP]2[/SUP]=75.5%, P<0.001).
Conclusions: AI technology could be used to evaluate disease severity in COVID-19 patients. Although it could not be considered an independent factor, there was no doubt that GGOs displayed more predictive value for further mechanical ventilation.

Keywords: Artificial intelligence; COVID-19; Chest computed tomography.
 
Back
Top Bottom